These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34002379)

  • 21. ["Covid-19 vaccines available in March 2021"].
    Ibrahimi N; Chaltiel D; Hill C
    Rev Prat; 2021 Mar; 71(3):239-244. PubMed ID: 34161019
    [No Abstract]   [Full Text] [Related]  

  • 22. Mix-and-match COVID vaccines trigger potent immune response.
    Callaway E
    Nature; 2021 May; 593(7860):491. PubMed ID: 34012131
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies.
    Salian VS; Wright JA; Vedell PT; Nair S; Li C; Kandimalla M; Tang X; Carmona Porquera EM; Kalari KR; Kandimalla KK
    Mol Pharm; 2021 Mar; 18(3):754-771. PubMed ID: 33464914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biosecurity of COVID-19 vaccines.
    Kantor IN
    Medicina (B Aires); 2020; 80 Suppl 6():104-106. PubMed ID: 33481741
    [No Abstract]   [Full Text] [Related]  

  • 25. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Canaday DH; Gravenstein S
    Clin Infect Dis; 2021 Feb; 72(3):513-514. PubMed ID: 33527123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial immunity and SARS-CoV-2 mutations.
    Hanage WP; Russell CA
    Science; 2021 Apr; 372(6540):354. PubMed ID: 33888632
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
    Mayo S; Monfort S
    J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Let me choose my COVID-19 vaccine".
    Dal-Ré R; Stephens R; Sreeharan N
    Eur J Intern Med; 2021 May; 87():104-105. PubMed ID: 33581978
    [No Abstract]   [Full Text] [Related]  

  • 32. Countries split from EU on COVID-19 vaccines.
    Holt E
    Lancet; 2021 Mar; 397(10278):958. PubMed ID: 33714379
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients.
    Yanay NB; Freiman S; Shapira M; Wishahi S; Hamze M; Elhaj M; Zaher M; Armaly Z
    Kidney Int; 2021 Jun; 99(6):1496-1498. PubMed ID: 33887318
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19.
    Singh N; Rai SN; Singh V; Singh MP
    J Chem Neuroanat; 2020 Dec; 110():101874. PubMed ID: 33091590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Covid: confined until the vaccine ?].
    Deleuze J
    Rev Prat; 2020 Nov; 70(9):931. PubMed ID: 33739744
    [No Abstract]   [Full Text] [Related]  

  • 37. Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution.
    Chen F; Gong S; Li RQ
    J Epidemiol; 2020 Dec; 30(12):574-575. PubMed ID: 33041320
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
    Usmani SS; Raghava GPS
    Front Immunol; 2020; 11():561851. PubMed ID: 33133071
    [No Abstract]   [Full Text] [Related]  

  • 39. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
    Ma C; Su S; Wang J; Wei L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):245-253. PubMed ID: 32437926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.